In its balance sheet at December 31, 2018, Gower Pharmaceuticals Corp. reported
ID: 2414744 • Letter: I
Question
In its balance sheet at December 31, 2018, Gower Pharmaceuticals Corp. reported inventory at a FIFO cost of $520,000 Gower Pharmaceuticals Corp. applied to the IRS for permission to adopt the dollar-value LIFO method of inventory valuation as of January 1, 2019. The company received the approval of the IRS based on its plan to use FIFO to determine the current cost of its ending inventory and an external price index in its dollar value LIFO calculations. The following information was obtained relative to the company's inventory for 2019 and 2020 Ending Inventory @ Current Price Index Date December 31, 2019 December 31, 2020 December 31, 2021 Year FIFO Prices $567,100 $576,800 $602,600 107 112 115 Complete the following table to compute the required inventory values under the dollar-value LIFO method. (12 points) a. Dollar-Value Dollar-Value Inventory at Price Inventory at Increase LIFO Layers at Price LIFO Layersat Current Cost Indx Base Yr Cost (Decrease) Base Yr Costs Index Current Costs $520,000 1.00 $520,000 $520,000 1) $520,000 1.00 $520,000 BASE YR 12/31 2019 12/31 2020 12/31 2021Explanation / Answer
Solution:
Computation of inventory at base year prices and change from prior year - Gower Pharmaceuticals Date Inventory at end of year prices Price index (Percentage) Inventory at base year prices Change from Prior Years 31-Dec-18 $520,000.00 100 $520,000.00 $0.00 31-Dec-19 $567,100.00 107 $530,000.00 $10,000.00 31-Dec-20 $576,800.00 112 $515,000.00 -$15,000.00 31-Dec-21 $602,600.00 115 $524,000.00 $9,000.00